Lee Gary K. 4
4 · Lyell Immunopharma, Inc. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Lee Gary K.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-11-10$16.16/sh−138$2,230→ 15,366 total
Footnotes (1)
- [F1]Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.